The Lymph&Co Foundation works with the motto “Away with Lymphoma”
In our vision innovation is the solution to the current major challenges in the treatment of patients with malignant lymphoma. It starts with the launch of innovative and excellent research and ends with social impact: development of new tools for the prevention, diagnosis and treatment of disease. The key is excellence.
The Lymph&Co Foundation supports groundbreaking scientific research that may lead the way to the cure or the improved therapeutic management of lymphoma. Therefore, Lymph&Co has issued three types of grants, i.e. the Lymph&Co Research Grant, a Consortium Initiation Grant and the Paul Fentener van Vlissingen Lymphoma Fellowship.